|
|
Free Trial
Description: Mang Yu is NexBio CEO/President/Founder. With a Lead411 subscription, NexBio email addresses ( @nexbio.com ) of the executives are viewable. Other information includes Mang Yu email, phone, and extension.
We provide information from your LinkedIn network, see company profile, and soon we will be showing twitter and facebook profiles as well. Typical management titles include VP, Chief, Vice President, Director, manager, & more. Similar names to Yu can be found at Executive Directory - Yu.
|
Add Mang Yu Information
Site Reference: http://www.nexbio.com/index.php?option=com_content&view=article&id=58&Itemid=58
Mang Yu, Ph.D., Chief Executive Officer
A winner of "Entrepreneur of 2008" award, Mang started his scientist-entrepreneur career 25 years ago, conducting biomedical research and teaching medical students as a faculty member at Fudan University in Shanghai. Under his direction, his present company, NexBio, has received numerous significant awards from the US government for drug development including a $50M National Institutes of Health contract for the development of Fludase®, NexBio’s novel influenza medicine. In addition, NexBio has received the “Scientific American 50” award for this innovative drug. Prior to founding NexBio, Mang was co-founder and Executive Vice President of Perlan Therapeutics. Perlan’s lead product, ColdSol, a common cold medicine, won the CONNECT Award for Most Innovative New Product in 2002. Prior to Perlan, Mang was a scientific co-founder of Immusol (now ItherX Pharmaceuticals) where he served as Director of Target Discovery and Gene Therapy, working on
|
|
